Genervon

Genervon is a clinical-stage biopharmaceutical company focused on novel treatments for neurodegenerative diseases and disorders. To date, no effective treatments have been developed for such conditions, but Genervon believes its new drug discovery paradigm has unlocked the potential for various therapeutic agents and even cures.